the drug development team

D2team consists of nonclinical and translational experts with extensive pharmaceutical discovery and development experience that offer comprehensive and integrated consultancy services for all aspects of drug discovery and development. From lead optimization and candidate selection, through creating IND enabling drug development plans, up to market authorization, D2team has the experience and breadth of skills to support projects at all stages. Whether a start-up, established biotech or pharmaceutical company, D2team can act as your full nonclinical drug development team, sympathetic to budgets and timelines but with an eye for future clinical and commercial needs. We have the skills and experience to address specific safety and mechanistic toxicology issues as they arise during development. The team is experienced in preparing assets for out-licensing, and to value other companies’ assets during investment due diligence. With years of experience in due diligence projects, the Drug Development Team can both advise on preparation for venture capital applications as well as supporting investors in their due diligence evaluations. The team will also advise on repurposing strategies to maximise the value or revive your assets, having experience in taking redundant drugs to clinical proof of concept assets that provided resale value. D2team is part of the Leiden Bioscience Park community and has a network of partners to fulfil all drug development needs. All our work will involve an internal peer review process to ensure maximum consideration for the success of your projects and issues however large or small.